Clinical Trial Update: Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of pembrolizumab, chemotherapy, and bevacizumab for cervical cancer was terminated; results have been posted on 2024-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chemotherapy (chemotherapy)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Miami | Conditions: Cervical Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-06-18